menu
    • menu

    Company profile for Nouscom AG

    NEW Drugs in Dev: 4
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Nouscom is a private oncology company developing next generation immunotherapies. Nouscom’s proprietary technology platform, Exovax, harnesses the full power of immune response by combining viral vectored genetic vaccines based on neoantigens with other immunomodulators. Nouscom is led by an experienced management team that has worked together for many years in previous successful enterprises, including IRBM/Merck and Okairo...
    Nouscom is a private oncology company developing next generation immunotherapies. Nouscom’s proprietary technology platform, Exovax, harnesses the full power of immune response by combining viral vectored genetic vaccines based on neoantigens with other immunomodulators. Nouscom is led by an experienced management team that has worked together for many years in previous successful enterprises, including IRBM/Merck and Okairos (acquired by GSK), and are veterans in the field of genetic vaccines.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Nouscom AGSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Bäumleingasse 18 BS, Basel-City 4051
    Telephone
    Telephone
    41612011831
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.nouscom.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/nouscom-ag
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nouscom Gets Fast Track For NOUS-209, In Lynch Syndrome Cancers
    Nouscom Gets Fast Track For NOUS-209, In Lynch Syndrome Cancers

    01 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/01/3304206/0/en/nouscom-receives-u-s-fda-fast-track-designation-for-nous-209-a-novel-immunotherapy-for-the-prevention-of-lynch-syndrome-associated-cancers.html

    GLOBENEWSWIRE
    01 Jun 2026
    Share Share
    Nouscom Unveils Positive Phase 1/2B Data For NOUS-209 At SITC
    Nouscom Unveils Positive Phase 1/2B Data For NOUS-209 At SITC

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183707/0/en/Nouscom-Presents-New-Positive-Phase-1-2b-data-of-NOUS-209-at-SITC-2025-Supporting-Plans-to-Initiate-Registration-Enabling-Study-for-Cancer-Interception-in-Lynch-Syndrome-Carriers.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Nouscom to Present Ph 1b/2 NOUS-209 Data in Lynch Syndrome
    Nouscom to Present Ph 1b/2 NOUS-209 Data in Lynch Syndrome

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177455/0/en/Nouscom-to-Present-New-Positive-Phase-1b-2-Clinical-and-Translational-Data-on-NOUS-209-Immunogenicity-and-Cancer-Interception-Potential-in-Lynch-Syndrome-Carriers-at-SITC-2025.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share
    Nouscom Reveals NOUS-209 Immunotherapy Success In MSI-H Cancer
    Nouscom Reveals NOUS-209 Immunotherapy Success In MSI-H Cancer

    12 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/12/3165248/0/en/Nouscom-Presents-Positive-Phase-2-Results-of-NOUS-209-Immunotherapy-Combined-with-Pembrolizumab-in-MSI-H-Metastatic-Colorectal-Cancer-Patients-Refractory-to-Anti-PD-1-Therapy-at-ES.html

    GLOBENEWSWIRE
    12 Oct 2025
    Share Share
    Nouscom’s NOUS-209 Shows Durable Response in Lynch Syndrome
    Nouscom’s NOUS-209 Shows Durable Response in Lynch Syndrome

    29 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/29/3070727/0/en/Nouscom-Presents-Positive-Final-Results-from-Completed-Phase-Ib-II-Study-of-Neoantigen-Immunotherapy-NOUS-209-at-AACR-2025-Demonstrating-a-Highly-Potent-and-Durable-Immune-Response.html

    GLOBENEWSWIRE
    29 Apr 2025
    Share Share
    Nouscom To Present Ph Ib/II NOUS-209 Data In Lynch Syndrome At AACR
    Nouscom To Present Ph Ib/II NOUS-209 Data In Lynch Syndrome At AACR

    25 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/25/3049177/0/en/Nouscom-to-Present-Final-Results-from-Successful-Phase-Ib-II-Trial-of-NOUS-209-in-People-Living-with-Lynch-Syndrome-Demonstrating-Powerful-Potential-to-Intercept-Cancer-in-its-Earl.html

    GLOBENEWSWIRE
    25 Mar 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search